PMID: 7523261Jan 1, 1994Paper

Epithelium modulates the kinetics of the response to substance P and its intrinsic activity in the guinea-pig trachea

Fundamental & Clinical Pharmacology
A Da SilvaY Landry

Abstract

The contractile response of guinea-pig tracheal preparations with or without epithelium to substance P has been studied in the presence or absence of thiorphan, an endopeptidase 24.11 inhibitor, paying special attention to the kinetics of the response. Without thiorphan, the response to substance P was greater in tracheal preparations without epithelium than in tracheal preparations with epithelium. The concentration-response curve was shifted to the left in the absence of the epithelium. In the presence of 10 microM thiorphan, the maximal contractile response induced by single doses of substance P (0.1 to 10 microM) was lower in tracheal preparations without epithelium. The maximal responses required 10 min in tracheal preparations with epithelium and 2 min in tracheal preparations without epithelium. These epithelium-dependent differences of reactivity remained in the presence of lipoxygenase or cyclooxygenase inhibitors and of selective antagonists of muscarinic, serotoninergic and histaminergic receptors, after the pre-treatment of tissues with capsaicin or compound 48/80 and in the presence of tetrodotoxin. The profile of the cumulative concentration-response curves for substance P was largely dependent on the time between...Continue Reading

References

Oct 1, 1978·The Journal of Investigative Dermatology·O HägermarkB Pernow
Mar 1, 1992·The Biochemical Journal·J L BuebY Landry
Feb 25, 1992·European Journal of Pharmacology·A Da SilvaY Landry
May 1, 1992·Journal of Applied Physiology·N GrundströmR G Andersson
Feb 1, 1991·Journal of Applied Physiology·C L ArmourJ L Black
Jun 1, 1990·Trends in Pharmacological Sciences·B P Roques, A Beaumont
Feb 1, 1990·Trends in Pharmacological Sciences·R G GoldieD W Hay
Dec 2, 1986·European Journal of Pharmacology·E Tschirhart, Y Landry
Sep 1, 1987·Canadian Journal of Physiology and Pharmacology·S Mansour, E E Daniel
Jan 1, 1989·Journal of Applied Physiology·J M FineD Sheppard
Feb 1, 1989·Journal of Applied Physiology·S A Shore, J M Drazen
Jan 1, 1989·International Archives of Allergy and Applied Immunology·C BertrandY Landry
Dec 1, 1989·Journal of Applied Physiology·D PavlovicR Pariente
Jan 1, 1989·The Journal of Clinical Investigation·K SekizawaJ A Nadel
Jul 1, 1986·Prostaglandins, Leukotrienes, and Medicine·S S Tucker, B M Weichman
Oct 1, 1986·Journal of Applied Physiology·N Frossard, F Muller
Mar 1, 1987·Biopharmaceutics & Drug Disposition·L G MillerR I Shader
Aug 1, 1988·Journal of Applied Physiology·K Stuart-Smith, P M Vanhoutte
Feb 1, 1988·British Journal of Pharmacology·C AdvenierE Naline
Apr 1, 1988·British Journal of Pharmacology·K A Lundblad, C G Persson
Feb 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·T P Kenakin, D Beek
Mar 1, 1986·British Journal of Pharmacology·M C Holroyde
Mar 1, 1985·Journal of Applied Physiology·N A FlavahanP M Vanhoutte
Nov 1, 1985·British Journal of Pharmacology·P J BarnesJ B Palmer
Nov 1, 1984·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·D T Tanaka, M M Grunstein
Sep 1, 1983·Acta Physiologica Scandinavica·J M LundbergA Saria
Jan 27, 1984·European Journal of Pharmacology·D RegoliJ Mizrahi
Dec 21, 1981·Life Sciences·R L HudginP L Wood
Jan 1, 1993·Fundamental & Clinical Pharmacology·C Bertrand, E Tschirhart

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.